Tolerance of a Cluster Schedule on the Treatment of Seasonal Allergic Respiratory Disease with Pollen Extracts Quantified in Mass Units

Journal of Investigational Allergology and Clinical Immunology

Volumn 13, Issue 4, 2003, Pages 221-227

  Moreno, C ^a   Fernandez Tavora L ^b   Acero, S ^c   Alonso, M D ^d   Barahona, M J ^a   Blanco, R ^c   Cistero A ^e   Conde, J ^k   Fernandez J ^f   Fernandez S ^g   Fernandez Rivas M ^d   Garcia B E ^h   Garcia Rodriguez R ^l   Camacho, E ^l   Gonzalez Quevedo T ⁱ   Gonzalo, A ^j   Guardia, P ^k   Sanchez Cano M ^l   Tabar, A I ^h   De La Torre, Fernando ^m  

^a HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^b Ambulatorio Virgen de la Cinta   (Spain)

^c HOSPITAL NUESTRA SEÑORA DE SONSOLES   (Spain)

^d HOSPITAL UNIVERSITARIO FUNDACIÓN ALCORCÓN   (Spain)

^e INSTITUT UNIVERSITARI DEXEUS   (Spain)

^f HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^g HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

^h Universidad Pública de Navarra   (Spain)

ⁱ HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^j HOSPITAL INFANTA CRISTINA   (Spain)

^k HOSPITAL UNIVERSITARIO VIRGEN MACARENA   (Spain)

^l HOSPITAL RAMÓN Y CAJAL   (Spain)

^m ALK ABELLÓ   (Denmark)

more..

Author keywords

Asthma; Cluster immunotherapy; Grasses; Mass units; Olive; Rhinitis

Indexed keywords

PANGRAMIN; POLLEN EXTRACT;

ADULT; ALLERGIC ASTHMA; ANAPHYLACTIC SHOCK; ANGIONEUROTIC EDEMA; ARTICLE; CLINICAL TRIAL; DOSE RESPONSE; DRUG TOLERABILITY; FEMALE; GRASS POLLEN; HUMAN; IMMUNOTHERAPY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OLIVE; POLLEN ALLERGY; RESPIRATORY TRACT ALLERGY; RHINOCONJUNCTIVITIS; SENSITIZATION; URTICARIA;

ADULT; ALLERGENS; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DRUG TOLERANCE; FEMALE; HUMANS; IMMUNIZATION; IMMUNOTHERAPY; MALE; OLEA; POLLEN; RESPIRATORY HYPERSENSITIVITY; RHINITIS, ALLERGIC, SEASONAL; SAFETY; SEASONS;

EID: 10744227744     PISSN: 10189068     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Van Bever, H.P., Stevens, W.J. Suppression of the late asthmatic reaction by hyposensitization in asthmatic children allergic to house dust mite (Dermatophagoides pteronyssinus). Clin Exp Allergy 1989; 19:399-404.
2. Van Bever, H.P., Stevens, W.J. Effect of hyposensitization upon the immediate and late asthmatic reaction and upon histamine reactivity in patients allergic to house dust mite (Dermatophagoides pteronyssinus). Eur Respir J 1992; 5: 318-322.
3. García Ortega, P., Merelo, A., Marrugat, J., Richart, C. Decrease of skin and bronchial sensitization following short-intensive scheduled immunotherapy in mite-allergic asthma. Chest 1993; 103:183-187.
4. Pichler, C.E., Marquardsen, A., Sparholt, S., Lowenstein, H., Bircher, A., Bischof, M., Pichler, W.J. Specific immunotherapy with Dermatophagoides pteronyssinus results in decreased bronchial reactivity. Allergy 1997; 52:274-283.
5. Vidal, C., Fernández-Tavora, L., Moreno, C., Guardia, P. Inmunoterapia cluster con un extracto depot de Dermatophagoides pteronyssinus: estudio prospectivo de tolerancia. Rev Esp Alergol Inmunol Clin 1997; 12(6):351-355.
6. Tabar, A.I., Muro, M.D., García, B.E., Alvarez, M.J., Acero, S., Rico, P., Olaguibel, J.M. Dermatophagoides pteronyssinus: cluster immunotherapy. A controlled trial of safety and clinical efficacy. Invest Allergol Clin Immunol 1999; 9:155-164.
7. Bucur, J., Dreborg, S., Einarsson, R., Ljungstedt-Pahlman, I., Nilsson, J.-E., Persson, G. Immunotherapy with dog and cat allergen preparations in dog-sensitive and cat-sensitive asthmatics. Ann Allergy 1989; 62:355-361.
8. Haugaard, L., Dahl, R. Immunotherapy in patients allergic to cat and dog dander. I. Clinical results. Allergy 1992; 47:249-254.
9. Malling, H.J., Dreborg, S., Weeke, B. Diagnosis and immunotherapy of molz allergy. V. Clinical efficacy and side effects of immunotherapy with Cladosporium herbarum. Allergy 1986; 41:507-519.
10. Dreborg, S., Agrell, B., Foucard, T., Kjellman, M., Koivikko, A., Nilsson, S.I. A double-blind, multicenter immunotherapy trial in children, using a purified and standardized Cladosporium herbarum preparation. I. Clinical results. Allergy 1986; 41:131-140.
11. Moreno, C., Fernández-Tavora, L., Justicia, J.L., Cabeza, N., Vidal, C. Búsqueda de una pauta idónea para iniciación de inmunoterapia con un extracto de Alternaria tenuis. Alergol Inmunol Clin 2001; 16:133-137.
12. Van Metre, T.E., Adkinson, N.F., Amodio, F.J., Kagey-Sobotka, A., Lichtenstein, L.M., Mardiney, M.R., Norman, P.S., Rosemberg, G.L. A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever. J Allergy Clin Immunol 1982; 69:181-193.
13. Norman, P.S., Lichtenstein, L.M., Kagey-Sobotka, A., Marsh, D.G. Controlled evaluation of allergoid in the immunotherapy of ragweed hay fever. J Allergy Clin Immunol 1982; 70:248-260.
14. Creticos, P.S., Van Metre, T.E., Mardiney, M.R., Rosenberg, G.L., Norman, P.S., Adkinson, N.F. Dose response of IgE and IgG antibodies during ragweed immunotherapy. J Allergy Clin Immunol 1984; 73:94-104.
15. Stevens, W.J., Verhelst, J.A., Van den Bogaert, W., Bridts, C.H. Clinical and biological evaluation of semi-rush and ordinary immunotherapy schemes in type I allergic respiratory diseases. Allergy 1985; 40:447-452.
16. Bousquet, J., Maasch, H., Martinot, B., Hejjaoui, A., Wahl, R., Michel, F.B. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol 1988; 82:439-446.
17. Fernández-Tavora, L., García, D. Inmunoterapia cluster con extractos de pólenes: estudios de tolerancia, cambios inmunológicos y eficacia clínica. Rev Esp Alergol Inmunol Clin 1991; 6(1):68-74.
18. Nielsen, L., Johnsen, C.R., Mosbech, H., Poulsen, L.K., Malling, H.-J. Antihistamine premedication in specific immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol 1996; 97:1207-1213.
19. Winther, L., Malling, H.J., Mosbech, H. Allergen-specific immunotherapy in birch- and grass-pollen-allergic rhinitis. II. Side effects. Allergy 2000; 55:827-835.
20. Walker, S.M., Pajno, G.B., Torres Lima, M., Wilson, D.R., Durham, S.R. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol 2001; 107:87-93.
21. Moreno, C., Fernández-Tavora, L., Vidal, C., Justicia, J.L., Guerra, F. Estudio prospectivo de seguridad de una pauta agrupada con extractos acuosos de pólenes. Alergol Inmunol Clin 2001; 16:95-101.
22. Moreno, C., Fernández-Távora, L., Justicia, J.L., Cabeza, N., Guerra, F. Perfil asistencial de una pauta agrupada de inmunoterapia con extractos de pólenes adsorbidos en hidróxido de aluminio. Alergol Inmunol Clin 2001; 16:329-334
23. Djurup, R., Malling, H.J., Sondergaard, I.B., Weeke, B. The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimes of venom immunotherapy. J Allergy Clin Immunol 1985; 76:46-55.
24. Müller, U., Lanner, A., Schmid, P., Bischof, M., Dreborg, S., Hoigné, R. A double blind study on immunotherapy with chemically modified honey bee venom: monomethoxy polyethylene glycol-coupled versus crude honey bee venom. Int Arch Allergy Appl Immunol 1985; 77:201-201.
25. Malling, H.J., Djurup, R., Sondergaard, I., Weeke, B. Clustered immunotherapy with yellow jacket venom. Evaluation of the influence of time interval on in vivo and in vitro parameters. Allergy 1985; 40:373-383.
26. Mosbech, H., Malling, H.-J., Biering, I., Böwadt, H., Soborg, M., Weeke, B., Lowenstein, H. Immunotherapy with yellow jacket venom. A comparative study including three different extracts, one adsorbed to aluminium hydroxide and two unmodified. Allergy 1986; 41:95-103.
27. Tarhini, H., Knani, J., Michel, F.B., Bousquet, J. Safety of venom immunotherapy administered by a cluster schedule. J Allergy Clin Immunol 1992; 89(6):1198-1199.
28. Ewan, P.W., Deighton, J., Wilson, A.B., Lachmann, P.J. Venom-specific IgG antibodies in bee and wasp allergy: lack of correlation with protection from stings. Clin Exp Allergy 1993; 23:647-660.
29. Moreno, C., Guerra, F. Inmunoterapia con veneno de himenópteros. Seguridad de una pauta agrupada. Alergol Inmunol Clin 1999; 14(5):315-321.
30. Fernández-Tavora, L., García, D. Aqueous extracts and cluster schedule: a good approach for immunotherapy build-up phase. Allergy 1995; 50(26): P-0592.
31. Mellerup, M.T., Hahn, G.W., Poulsen, L.K., Malling, H.J. Safety of allergen specific immunotherapy. Relation between dosage regimen, allergen extract, disease, and systemic side effects during induction treatment. Clin Exp Allergy 1999; 30:1423-1429.
32. WHO Position Paper. Allergen immunotherapy: Therapeutic vaccines for allergic diseases. J. Bousquet, R.F. Lockey, H.-J. Malling (eds.). Allergy 1998, 44(53):6-42.
33. Lombardero, M., González, R., Duffort, O., Juan, F., Ayuso, R., Ventas, P., Cortés, C., Carreira, J. Evaluación de la actividad biológica total y composición alergénica de extractos alergénicos. Allergol et Immunopathol 1986; 14:189-198.
34. Position Paper. Immunotherapy. H.J. Malling, B. Weeke (eds.). Allergy 1993, 14(48):9-35.
35. Tabar, A.I., García, B.E., Rodríguez, A., Olaguibel, J.M., Muro, M.D., Quirce, S. A prospective safety-monitoring study of immunotherapy with bilogically standardized extracts. Allergy 1993; 48:450-453.
36. Horak, F. Pangramin-Praxisstudie: Nebenwirkungen und Therapieerfolg unter einer Hyposensibilisierung mit standardisierten Allergenen. Allergologie 1988; 11:112-119.
37. Jutel, M., Pichler, W.J., Skrbic, D., Urwyler, A., Dahinden, C., Müller, U.R. Bee venom immunotherapy results in decrease of IL-4 and IL-5 and increase of IFN-γ secretion in specific allergen-stimulated T-cell cultures. J Immunol 1995; 154:4187-4194.